---
category: trading
circular_id: db8642f8d689a783
date: '2025-12-18'
description: Vivimed Labs Ltd. equity shares will be included under 'B' group effective
  December 26, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={5BECB453-5EE6-4D63-A304-44B64F4886E3}&noticeno=20251218-19&dt=12/18/2025&icount=19&totcount=58&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Group reclassification from current group to B group affects trading
  parameters and investor eligibility for Vivimed Labs shares
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251218-19&attachedId=
processing:
  attempts: 1
  content_hash: 816aeaee61c4a9e8
  processed_at: '2025-12-18T18:52:09.699292'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-18T11:18:06+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={5BECB453-5EE6-4D63-A304-44B64F4886E3}&noticeno=20251218-19&dt=12/18/2025&icount=19&totcount=58&flag=0
severity: medium
source: bse
stocks:
- VIVIMED
tags:
- group-change
- b-group
- equity
- vivimed-labs
- trading
title: 'Change in Group of Equity Shares of Vivimed Labs Ltd. (Scrip Code: 532660)'
---

## Summary

BSE has announced that equity shares of Vivimed Labs Ltd. (Scrip Code: 532660) will be reclassified and included under 'B' group effective December 26, 2025. This change in group classification will modify the trading parameters and characteristics applicable to the company's shares.

## Key Points

- Vivimed Labs Ltd. (Scrip Code: 532660) will move to 'B' group
- Change effective from December 26, 2025
- Notice issued on December 18, 2025
- Trading members have been notified of this reclassification
- Contact person: Ms. Kinjal More (+91-7304278788) for clarifications

## Regulatory Changes

The equity shares of Vivimed Labs Ltd. will be reclassified from their current group to 'B' group. This reclassification changes the trading characteristics and applicable rules for the security under BSE's group classification framework.

## Compliance Requirements

- Trading members must update their systems to reflect the new group classification
- Trading members should ensure compliance with all trading rules applicable to 'B' group securities
- Any queries or clarifications should be directed to Ms. Kinjal More on +91-7304278788

## Important Dates

- **Notice Date**: December 18, 2025
- **Effective Date**: December 26, 2025 - Vivimed Labs shares will trade under 'B' group from this date

## Impact Assessment

**Market Impact**: Medium - The reclassification to 'B' group may affect trading volumes and investor participation as 'B' group securities typically have different trading parameters compared to other groups.

**Operational Impact**: Trading members need to update their systems and ensure their trading infrastructure is configured for 'B' group characteristics before the effective date.

**Investor Impact**: Investors trading in Vivimed Labs shares should be aware that group changes can affect margin requirements, settlement processes, and overall trading dynamics for the security.